Ganga Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Ganga Pharmaceuticals Ltd. on BSE

Load latest

16 Jan 2019

Corp. Note

Ganga Pharmaceuticals Ltd - 539680 - Shareholding for the Period Ended December 31, 2018

BSE India

Ganga Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here

Ganga Pharmaceuticals Ltd.

10 Jan 2019

Corp. Note

Ganga Pharmaceuticals Ltd - 539680 - Statement Of Investor Complaints For The Quarter Ended December 2018

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Bharat SharmaDesignation :- Director

Ganga Pharmaceuticals Ltd.

03 Dec 2018

Company Update

Change In Name Of Registrar & Share Transfer Agent - Karvy Computershare Private Limited

BSE India

The Company has been informed that pursuant to Order of the Hyderabad Bench of the National Company Law Tribunal (NCLT Order), the operations of Karvy Computershare Private Limited, the Share Transfer Agents of the Company (KCPL) have been transferred to Karvy Fintech Private Limited (Karvy Fintech) with effect from 17th November, 2018. The Company has been further informed that pursuant to the NCLT Order all the existing agreements to...

pdf

Ganga Pharmaceuticals Ltd.

05 Nov 2018

Result

Unaudited Financial Results For The Half Year Ended On September 30, 2018.

BSE India

Un-audited Financial Results for the half year ended on September 30, 2018 as adopted and approved by the Board of Directors together with the limited review report of the Auditors thereon

pdf

Ganga Pharmaceuticals Ltd.

25 Oct 2018

Board Meeting

Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results Of The Company For The …

BSE India

GANGA PHARMACEUTICALS LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2018 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the half year ended September 30, 2018

pdf

Ganga Pharmaceuticals Ltd.

12 Oct 2018

Company Update

Certificate Under Clause 40(10) Of SEBI (LODR) Regulation, 2015 For The Half Year Ended On September …

BSE India

Pursuant to the provisions of clause 40(10) of SEBI (LODR) Regulation, 2015, please find enclosed herewith the Certificate for the half year ended September 30, 2018

pdf

Ganga Pharmaceuticals Ltd.

12 Oct 2018

Company Update

Statement Of Investor Complaints For The Quarter Ended September 2018

BSE India

Ganga Pharmaceuticals Ltd.

11 Oct 2018

Company Update

Shareholding for the Period Ended September 30, 2018

BSE India

Ganga Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here

Ganga Pharmaceuticals Ltd.

06 Sep 2018

Company Update

Outcome Of Board Meeting (Appointment Of CFO)

BSE India

Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. September 06, 2018 (commenced at 4:30 p.m. and concluded at 5:00 p.m.) considered and approved the appointment of Mr. Anagh B. Sharma as Chief Financial Officer (CFO) of the Company.

pdf

Ganga Pharmaceuticals Ltd.

30 Aug 2018

Corp. Note

Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

BSE India

This is to inform you that Mr. Ganesh Jyothimani Paradeshi, Chief Financial Officer (CFO) of the Company has resigned with effect from August 30, 2018. We request you to kindly take the above on record.

pdf

Is Ganga Pharmaceuticals Ltd. worth buying?

6 Votes:

Buy 33.33%

Sell 50.0%

Hold 16.67%